Recent Updates — SNES
The Nasdaq Stock Market notified SenesTech that its common stock no longer meets the minimum bid price requirement for continued listing, as the closing price closed below $1.00 per share for 30 consecutive business days. The company has an initial compliance period of 180 calendar days, ending April 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. Failure to comply may result in delisting proceedings. SenesTech operates in the sustainable rodent population management industry, providing fertility control solutions and monitoring services.
SenesTech announced preliminary third-quarter 2026 revenue of approximately $1.1 million, marking the highest quarterly revenue in company history and the first quarter exceeding the $1 million threshold. This represents roughly 40% sequential growth from Q2 2026 and 55% year-over-year growth compared to Q3 2025. The company attributes this momentum to scaling e-commerce, expanding subscription revenue, and increasing traction in its B2B segment. Definitive financial results are expected the week of November 9, 2026. SenesTech develops rodent birth control products and sustainable population management solutions for consumer and professional markets.
SenesTech reported record second-quarter 2026 financial results for the period ended June 30, 2026. Total revenue increased 56% sequentially to a record $770,000 and rose 23% year-over-year from $625,000 in Q2 2025. Gross margin reached a company-record 73.6%, up from 68.5% in the prior quarter. E-commerce revenue more than tripled to $511,000, driven by Amazon sales increasing fivefold to $349,000 under direct management. Net loss improved sequentially to $1.8 million, while cash and cash equivalents totaled $5.1 million at quarter-end. The company operates in the pest control industry, manufacturing fertility control products for rodent population management.
SenesTech announced that its active online subscription customer base more than doubled in the second quarter of 2026 compared to the first quarter, reaching a record level. The company's e-commerce business grew 186% during this period, driven by investments in Amazon, SenesTech.com, and digital marketing, as well as the transition to direct management of its Amazon channel and Shopify platform. This expansion reinforces the recurring revenue model for products like Evolve and ContraPest. SenesTech operates in the pest control industry, providing rodent birth control solutions.